Merck announced that within the scope of a capital increase by the Israeli start-up company QLight Nanotech, it is acquiring an interest in the Jerusalem-based company. QLight Nanotech is a spin-off subsidiary of Yissum, the technology transfer company of the Hebrew University of Jerusalem. It develops products for use in displays and energy-efficient light sources based on semiconductor nanoparticles known as quantum dots.
The transaction is expected to close in the second quarter of 2012. With this investment Merck will hold an equity stake in the company.
For more than three years, QLight Nanotech and Merck have been carrying out joint research as part of a partnership program sponsored by the Israeli Ministry of Industry, Trade and Labor.
- Merck KGaA, Darmstadt, Germany